Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 48,100.0 | $37.2M | 4.58% | -13K | -21.7% | $772.64 | -9.6% |
| 2 | LLY | LILLY ELI & CO | Healthcare | 33,715.0 | $31.0M | 3.83% | -9K | -20.1% | $919.77 | +9.5% |
| 3 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 36,846.0 | $17.0M | 2.10% | -11K | -23.2% | $460.99 | -8.6% |
| 4 | — | CENCORA INC | — | 52,375.0 | $16.5M | 2.03% | -11K | -17.4% | $314.14 | — |
| 5 | ABBV | ABBVIE INC | Healthcare | 71,575.0 | $15.6M | 1.92% | -39K | -35.3% | $217.49 | -3.7% |
| 6 | MCK | MCKESSON CORP | Healthcare | 16,850.0 | $14.6M | 1.80% | -9K | -34.2% | $865.36 | -12.1% |
| 7 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 100,841.0 | $13.3M | 1.64% | -25K | -19.6% | $131.74 | +20.3% |
| 8 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 163,000.0 | $13.1M | 1.61% | -30K | -15.8% | $80.08 | +1.6% |
| 9 | UNH | UNITED HEALTH GROUP INC | Healthcare | 45,500.0 | $12.3M | 1.52% | -9K | -17.1% | $270.59 | +45.6% |
| 10 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 475,000.0 | $11.9M | 1.47% | -136K | -22.3% | $25.01 | +4.4% |
| 11 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 207,000.0 | $11.7M | 1.44% | -8K | -3.7% | $56.49 | -12.1% |
| 12 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 34,465.0 | $11.4M | 1.41% | -11K | -24.5% | $330.87 | -13.5% |
| 13 | AXSM | AXSOME THERAPEUTICS INC | Healthcare | 63,800.0 | $10.8M | 1.33% | -51K | -44.4% | $169.02 | +34.5% |
| 14 | THC | TENET HEALTHCARE CORP | Healthcare | 54,000.0 | $10.2M | 1.26% | -23K | -29.4% | $188.71 | +4.2% |
| 15 | LIVN | LIVANOVA PLC | Healthcare | 155,000.0 | $9.9M | 1.22% | -35K | -18.4% | $63.56 | +10.1% |
| 16 | GKOS | GLAUKOS CORP | Healthcare | 84,000.0 | $9.0M | 1.12% | -126K | -60.0% | $107.66 | +33.8% |
| 17 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 379,250.0 | $8.9M | 1.09% | -108K | -22.1% | $23.36 | -13.4% |
| 18 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 92,605.0 | $8.6M | 1.06% | -14K | -12.8% | $92.38 | +10.6% |
| 19 | PNTG | PENNANT GROUP INC | Healthcare | 275,399.0 | $8.4M | 1.04% | -82K | -22.9% | $30.48 | +16.6% |
| 20 | NUVL | NUVALENT INC | Healthcare | 81,200.0 | $8.3M | 1.03% | -82K | -50.3% | $102.45 | -0.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.9%
Technology
1.1%